My art! MintyMural
Other reblogs! MintysMemes
Resources! MintyManual
(Coming soon)
My YouTube channel where I play guitar and draw things yes I promise I’ll record something it be up any day now I swear :’)

roma★
hello vonnie
occasionally subtle
Cosimo Galluzzi
NASA
One Nice Bug Per Day
taylor price
Three Goblin Art
d e v o n
Game of Thrones Daily
noise dept.

★
Keni

Discoholic 🪩

PR's Tumblrdome
Show & Tell

Andulka

#extradirty

祝日 / Permanent Vacation
Misplaced Lens Cap
seen from United States
seen from United States
seen from Germany
seen from China
seen from Canada
seen from United States
seen from Indonesia

seen from China
seen from Portugal
seen from Egypt

seen from United States

seen from South Africa

seen from Malaysia
seen from France
seen from United States
seen from Indonesia

seen from Pakistan
seen from United States

seen from Singapore
seen from Ukraine
@mintymusician
My art! MintyMural
Other reblogs! MintysMemes
Resources! MintyManual
(Coming soon)
My YouTube channel where I play guitar and draw things yes I promise I’ll record something it be up any day now I swear :’)

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
the three laws of tragedies (insp)
made you some graphics to help you remember
the people yearn for nonplastic fabrics

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
the people yearn for nonplastic fabrics
the people yearn for nonplastic fabrics
the people yearn for nonplastic fabrics
the people yearn for nonplastic fabrics
Man notices an Eagle eyeing the fish he just caught
*gets back to the nest* baby you are NEVER gonna believe how i got this fish

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
From Veronica Tucker via Pinterest
For millions of people managing type 2 diabetes, mornings begin the same way — a needle, a dose, and a quiet mental note to do it all again
"For millions of people managing type 2 diabetes, mornings begin the same way — a needle, a dose, and a quiet mental note to do it all again tomorrow.
That routine just changed.
On March 26, 2026, the U.S. Food and Drug Administration approved Awiqli (insulin icodec-abae), developed by Novo Nordisk, as the first and only once-weekly basal insulin ever approved for adults with type 2 diabetes in the United States.
This is not a minor update to an existing drug.
It is the first entirely new class of basal insulin to reach U.S. patients in more than two decades.
Instead of injecting insulin every single day, people with type 2 diabetes using Awiqli will only need one shot per week, on the same day, every week.
That means reducing from 365 injections a year down to just 52.
For anyone who has ever felt the weight of that daily ritual — the anxiety of forgetting, the physical discomfort, the constant reminder that their body needs help — this approval represents something much bigger than a dosing schedule.
It represents relief.
How the Drug Actually Works
Understanding why this injection lasts a full week requires a quick look inside the body.
Most traditional basal insulins are absorbed into the bloodstream and begin breaking down within 24 hours, which is why patients need a fresh dose every day to maintain stable blood sugar levels.
Awiqli works differently.
Its active ingredient, insulin icodec-abae, is engineered to loosely attach to a blood protein called albumin, which is found naturally and abundantly in the bloodstream.
This attachment creates a slow-release reservoir.
Instead of flooding the system and fading fast, the insulin releases gradually and consistently over an entire seven-day period, keeping blood sugar in a healthy range around the clock...
The FDA reviewed and ultimately declined to approve it for people with type 1 diabetes, citing concerns about a modestly increased risk of hypoglycemia in that population specifically.
Some regulatory agencies in other countries, including the European Union, Canada, Australia, and Japan, have approved Awiqli for both type 1 and type 2 diabetes, but for now the U.S. approval is limited to type 2...
What Comes Next
Awiqli is not standing alone in this space for long.
Eli Lilly is developing its own once-weekly basal insulin, called efsitora alfa, which is currently in late-stage clinical trials.
If that drug also earns FDA approval, it would give patients and doctors two once-weekly options to choose from, allowing for personalized decisions based on a patient’s health profile, insurance coverage, and individual response.
The broader direction of travel in diabetes care is unmistakable.
Fewer injections, smarter formulations, and better integration with digital tools like continuous glucose monitors and insulin-tracking apps are all converging toward a future where managing diabetes requires less daily mental effort without becoming any less medically precise...
A Small Shot With Large Implications
It is easy to look at a once-weekly injection and see only a scheduling change.
But the science behind Awiqli, the scale of the ONWARDS trials, and the consistent satisfaction reported by patients all point toward something that matters far more than convenience.
Diabetes management has always asked a lot of people.
It asks for daily vigilance, daily discipline, and a daily willingness to confront one’s own condition, sometimes in uncomfortable or inconvenient circumstances.
Anything that reduces that load, without reducing the quality of care, is worth taking seriously.
For the more than 37 million Americans living with diabetes, and the hundreds of millions more around the world, a simpler weekly routine could mean the difference between a treatment plan that works on paper and one that actually works in a person’s life.
That is the real significance of what the FDA approved on March 26, 2026.
Not just a new drug.
A new way of keeping people healthy, one week at a time."
-via Science Aim, March 29, 2026.
Compound bows? Fixed it mate!
Hey look, there’s more content here!
drew over something i wrote for a class and liked :] sorry the cars are lowkey ugly, its because I fucking hate cars and cant be bothered to learn what they look like beyond ominous hunks of metal
edit: transcript of the poem by itself under the cut

Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
OP hand-drew hundreds of small cards (cr 小狐哥)
bonus/proof:
we tipped her well dw. best waitress ever 🍒